OS Therapies OSTX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on assets | -610.8%-146pp | -464.6%-130pp | -334.6%-89.5pp | -245.1%+181pp | -426.5%-146pp | |
| Liquidity | ||||||
| Current ratio | 0.1×0.0× | 0×-0.5× | 0.6×-0.5× | 1×-0.1× | 1.2×0.0× | |
| Quick ratio | 0.1×0.0× | 0×-0.5× | 0.6×-0.5× | 1×-0.1× | 1.2×0.0× | |
| Cash ratio | 0.1×0.0× | 0×-0.4× | 0.5×-0.4× | 0.8×0.0× | 0.8×-0.4× | |
| Leverage | ||||||
| Debt-to-assets | 2.7×— | —— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | -$0.28-34.3% | -$0.21-283% | $0.11-42.2% | $0.20+200% | -$0.20+58.1% | |
| Valuation | ||||||
| Market capitalization | $84.62M+65.5% | $49.3M-20.5% | $62.02M+28.3% | $48.33M+44.2% | $33.52M-63.1% | |
| Enterprise value | $103.7M— | —— | —— | —— | —— | |
| Earnings yield | -41.9%-13.8pp | -58.3%-28.8pp | -29.5%+0.1pp | -29.5%+4.2pp | -33.7%-23.9pp |
Questions, answered.
- Where do OS Therapies's ratios come from?
- Every ratio is computed from OS Therapies's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.